Nalaganje...
EFFICACY AND SAFETY OF THERAPY WITH ATORVASTATIN IN HIGH DOSES
Large epidemiological trails shown that hypercholesterolemia is one of the main risk factor of ischemic heart disease (IHD). Correction of the hypercholesterolemia with GmGKoA reductase inhibitors (statins) essentially reduces IHD morbidity and mortality. The lower serum level of low density lipopro...
Shranjeno v:
| Glavni avtor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Stolichnaya Izdatelskaya Kompaniya
2016-01-01
|
| Serija: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Teme: | |
| Online dostop: | https://www.rpcardio.com/jour/article/view/820 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|